Publications Office of the EU
WR-1/24 Dostawa produktów leczniczych. - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

WR-1/24 Dostawa produktów leczniczych.

Overview
  • Awarded
    03/02/2025
  • Today
    07/02/2025
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Zachodniopomorskie Centrum Onkologii
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: PL424 Miasto Szczecin
Business sector (Main CPV)
33652100 Antineoplastic agents
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
1,005,475.00 PLN
Procedure details
Tender reference number
Not available
Description

Dostawa produktów leczniczych.

Submission Method
Not available
Tenders may be submitted
Not available
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
PL424 Miasto Szczecin
PL Polska
CPV code

33652100 - Antineoplastic agents

Award method
Criterion:
Type: price
Description: cena jest jedynym kryterium oceny ofert
Weight (percentage, exact): 100
Estimated value
Not available
Final contracted value
1,005,475.00 PLN
Award of contract
Official name: Astrazeneca Kft.
Postal address:
Town: Budapeszt
Postal code: 1117
Country:
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.